Free Trial

Martin Currie Ltd. Has $1.09 Million Holdings in Xylem Inc. (NYSE:XYL)

Xylem logo with Business Services background

Key Points

  • Martin Currie Ltd. reduced its stake in Xylem Inc. by 17.9% in the first quarter, owning 9,127 shares worth approximately $1.09 million as of their latest SEC filing.
  • In recent ratings, analysts have shown a positive outlook on Xylem, with the consensus rating being a "Moderate Buy" and an average price target of $151.57.
  • Xylem announced a quarterly dividend of $0.40 per share, with a dividend yield of 1.1%, to be paid on September 25th to stockholders of record on August 28th.
  • Looking to export and analyze Xylem data? Unlock 5 Weeks of MarketBeat All Access for Just $5. Claim Your Limited-Time Discount.

Martin Currie Ltd. lessened its holdings in shares of Xylem Inc. (NYSE:XYL - Free Report) by 17.9% during the first quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 9,127 shares of the industrial products company's stock after selling 1,993 shares during the period. Martin Currie Ltd.'s holdings in Xylem were worth $1,090,000 as of its most recent filing with the SEC.

A number of other hedge funds have also bought and sold shares of XYL. Valley National Advisers Inc. raised its stake in Xylem by 84.9% during the first quarter. Valley National Advisers Inc. now owns 220 shares of the industrial products company's stock worth $26,000 after buying an additional 101 shares during the last quarter. Perkins Coie Trust Co bought a new stake in Xylem in the first quarter valued at $27,000. Center for Financial Planning Inc. increased its stake in Xylem by 52.0% in the first quarter. Center for Financial Planning Inc. now owns 266 shares of the industrial products company's stock valued at $32,000 after purchasing an additional 91 shares in the last quarter. Heck Capital Advisors LLC bought a new stake in Xylem in the fourth quarter valued at $36,000. Finally, Headlands Technologies LLC increased its stake in Xylem by 90.6% in the first quarter. Headlands Technologies LLC now owns 305 shares of the industrial products company's stock valued at $36,000 after purchasing an additional 145 shares in the last quarter. Institutional investors own 87.96% of the company's stock.

Analyst Upgrades and Downgrades

Several equities research analysts have weighed in on XYL shares. Royal Bank Of Canada lifted their price target on shares of Xylem from $143.00 to $147.00 and gave the company an "outperform" rating in a research note on Wednesday, April 30th. Raymond James Financial upgraded shares of Xylem to a "hold" rating in a report on Thursday, May 15th. UBS Group lifted their price objective on shares of Xylem from $164.00 to $168.00 and gave the company a "buy" rating in a report on Tuesday, August 5th. Robert W. Baird cut their price target on shares of Xylem from $149.00 to $146.00 and set an "outperform" rating on the stock in a report on Wednesday, April 30th. Finally, Stifel Nicolaus boosted their target price on shares of Xylem from $162.00 to $175.00 and gave the company a "buy" rating in a research note on Friday, August 1st. Three equities research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and an average price target of $151.57.

Read Our Latest Research Report on XYL

Xylem Stock Performance

NYSE XYL opened at $141.87 on Friday. The company's 50 day moving average is $132.54 and its 200-day moving average is $125.70. The company has a quick ratio of 1.43, a current ratio of 1.90 and a debt-to-equity ratio of 0.17. The firm has a market cap of $34.53 billion, a P/E ratio of 36.85, a price-to-earnings-growth ratio of 2.49 and a beta of 1.11. Xylem Inc. has a 12-month low of $100.47 and a 12-month high of $145.33.

Xylem (NYSE:XYL - Get Free Report) last posted its earnings results on Thursday, July 31st. The industrial products company reported $1.26 earnings per share for the quarter, topping analysts' consensus estimates of $1.15 by $0.11. The business had revenue of $2.30 billion for the quarter, compared to analyst estimates of $2.20 billion. Xylem had a net margin of 10.74% and a return on equity of 10.33%. Xylem's revenue was up 6.1% on a year-over-year basis. During the same quarter in the prior year, the firm posted $1.09 EPS. Sell-side analysts predict that Xylem Inc. will post 4.65 earnings per share for the current year.

Xylem Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Thursday, September 25th. Stockholders of record on Thursday, August 28th will be issued a $0.40 dividend. This represents a $1.60 dividend on an annualized basis and a dividend yield of 1.1%. Xylem's payout ratio is 41.56%.

Xylem Profile

(Free Report)

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.

Further Reading

Want to see what other hedge funds are holding XYL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Xylem Inc. (NYSE:XYL - Free Report).

Institutional Ownership by Quarter for Xylem (NYSE:XYL)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Xylem Right Now?

Before you consider Xylem, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Xylem wasn't on the list.

While Xylem currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Palantir’s Soaring Valuation—Justified or Overhyped?
3 Stocks With Explosive Upside
September Slowdown: 3 Stocks to Buy When the Pullback Comes

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines